Literature DB >> 8818917

Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach.

A Zanchetti, G Mancia.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8818917     DOI： 10.1097/00004872-199607000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  5 in total

Review 1.  Pharmacoeconomics of hypertension management: the place of combination therapy.

Authors:  E Ambrosioni
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Intermediate versus hard end points in clinical trials on hypertension.

Authors:  Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 3.  Pharmacoeconomic considerations in the management of hypertension.

Authors:  H Pardell; R Tresserras; P Armario; R Hernández del Rey
Journal:  Drugs       Date:  2000       Impact factor: 9.546

4.  Hypertension in perspective.

Authors:  W F Terpstra; F Zijlstra
Journal:  Neth Heart J       Date:  2005-05       Impact factor: 2.380

5.  Treatment of high blood pressure and gain in event-free life expectancy.

Authors:  Behrouz Kassaï; Jean-Pierre Boissel; Michel Cucherat; Florent Boutitie; François Gueyffier
Journal:  Vasc Health Risk Manag       Date:  2005
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.